A private biotechnology company focused on longevity solutions, backed by Sam Altman.
3 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Retro Biosciences in the last 30 days yet.
The 2 sources with the most insights about Retro Biosciences on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Received a $200 million investment from Sam Altman, signaling high-stakes venture interest at the intersection of AI and biology.
Backed by Sam Altman, representing a high-growth 'moonshot' opportunity in the longevity sector.
Mentioned as a key player in the high-potential longevity and age-reversal sector, which is expected to see a major scientific breakthrough.
Received a $200 million investment from Sam Altman, signaling high-stakes venture interest at the intersection of AI and biology.
Backed by Sam Altman, representing a high-growth 'moonshot' opportunity in the longevity sector.
Mentioned as a key player in the high-potential longevity and age-reversal sector, which is expected to see a major scientific breakthrough.
Other assets that creators frequently mention in the same content as Retro Biosciences.
The most active sources covering Retro Biosciences (PRIVATE) on Kazuha are PHD Ventures, The New York Times. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 3 AI-extracted insights about Retro Biosciences (PRIVATE) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Retro Biosciences (PRIVATE) most frequently also discuss PRIVATE, PRIVATE, BTC, GSK, Figure AI, Inc.. See the "Discussed alongside" section above for full asset pages.